These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 23080479

  • 1. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 3. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V, Ververs TF, Visser GH, Gazzolo D.
    Curr Med Chem; 2012 Jun; 19(27):4554-61. PubMed ID: 22876893
    [Abstract] [Full Text] [Related]

  • 4. Safety of antidepressant use in pregnant and nursing women.
    Lamberg L.
    JAMA; 1999 Jul 21; 282(3):222-3. PubMed ID: 10422977
    [No Abstract] [Full Text] [Related]

  • 5. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN, Bos AF.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2873-4. PubMed ID: 18257430
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.
    J Clin Psychiatry; 2004 Feb 29; 65(2):230-7. PubMed ID: 15003078
    [Abstract] [Full Text] [Related]

  • 7. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.
    Arch Gen Psychiatry; 2012 Jul 29; 69(7):706-14. PubMed ID: 22393202
    [Abstract] [Full Text] [Related]

  • 8. Safety of newer antidepressants in pregnancy.
    Way CM.
    Pharmacotherapy; 2007 Apr 29; 27(4):546-52. PubMed ID: 17381382
    [Abstract] [Full Text] [Related]

  • 9. [The safety profile of escitalopram in pregnancy and breastfeeding].
    Bellantuono C, Orsolini L, Bozzi F.
    Riv Psichiatr; 2013 Apr 29; 48(6):407-14. PubMed ID: 24441517
    [Abstract] [Full Text] [Related]

  • 10. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 29; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 11. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD, Åkerud H, Sundström Poromaa I.
    Eur J Pharmacol; 2015 Apr 15; 753():257-62. PubMed ID: 25094036
    [Abstract] [Full Text] [Related]

  • 12. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK, Melinder A.
    Child Neuropsychol; 2015 Apr 15; 21(5):543-69. PubMed ID: 25089614
    [Abstract] [Full Text] [Related]

  • 13. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA.
    N Engl J Med; 2006 Feb 09; 354(6):579-87. PubMed ID: 16467545
    [Abstract] [Full Text] [Related]

  • 14. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L, Slack-Smith L, Stanley FJ, Bower C.
    CNS Drugs; 2012 Jul 01; 26(7):e1-14. PubMed ID: 22712699
    [Abstract] [Full Text] [Related]

  • 15. [SSRIs and pregnancy: a review of the literature].
    Soufia M, Aoun J, Gorsane MA, Krebs MO.
    Encephale; 2010 Dec 01; 36(6):513-6. PubMed ID: 21130237
    [Abstract] [Full Text] [Related]

  • 16. Selective serotonin reuptake inhibitors in pregnancy and lactation.
    Gupta S, Masand PS, Rangwani S.
    Obstet Gynecol Surv; 1998 Dec 01; 53(12):733-6. PubMed ID: 9870234
    [Abstract] [Full Text] [Related]

  • 17. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].
    Watanabe O.
    Seishin Shinkeigaku Zasshi; 2014 Dec 01; 116(12):996-1004. PubMed ID: 25823351
    [Abstract] [Full Text] [Related]

  • 18. [Selective serotonin reuptake inhibitors and pregnancy].
    Hassanzadeh T, Pedersen LH, Videbech P.
    Ugeskr Laeger; 2014 Feb 03; 176(3):236-9. PubMed ID: 24629751
    [Abstract] [Full Text] [Related]

  • 19. Are SSRIs safe for pregnant and breastfeeding women?
    Misri S, Burgmann A, Kostaras D.
    Can Fam Physician; 2000 Mar 03; 46():626-8, 631-3. PubMed ID: 10752001
    [Abstract] [Full Text] [Related]

  • 20. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL, Brain UM, Underhill CM, Hammond GL, Oberlander TF.
    Psychoneuroendocrinology; 2012 Jul 03; 37(7):1019-28. PubMed ID: 22177580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.